Advancing the Science and Technology of Corneal Crosslinking

Avedro is a privately held medical device and pharmaceutical company advancing the science and technology of corneal crosslinking. The Company’s advanced crosslinking technology makes an entirely new crosslinking procedure possible; Lasik Xtra^®, intra-operative accelerated crosslinking following the creation of the flap during Lasik. Today more than 50,000 eyes around the world have been treated with Avedro’s KXL ^® System for Accelerated Crosslinking. Outside the US, Avedro has obtained CE Mark for its KXL System and its family of riboflavin products. Learn More

Avedro’s products are not available for sale in the US.

MA-00038F